Turnstone Biologics
Company Information
Turnstone Biologics was a clinical-stage biotechnology company focused on cell therapies for solid tumors. Public materials describe a differentiated approach based on selecting and expanding tumor-reactive tumor-infiltrating lymphocytes rather than using bulk TIL products. Its pipeline historically included TIDAL-01 and related programs intended to improve response rates in difficult-to-treat cancers.
Industry Focus and Technologies
Cell therapy, oncology, tumor-infiltrating lymphocyte therapy, immuno-oncology, solid tumor therapeutics, translational cancer research.
Location
Ottawa, Ontario, Canada
Company Size and Stage
Products, Platforms or Focus Areas
TIL-based cell therapy programs for solid tumors, neoantigen-reactive T-cell selection, and TIDAL-01 process and pipeline assets developed for adoptive cell therapy.